Equitable Trust CO Dexcom Inc Transaction History

Equitable Trust CO

$1.47 Billion
Q3 2024

A detailed history of Equitable Trust CO transactions in Dexcom Inc stock. As of the latest transaction made, Equitable Trust CO holds 18,243 shares of DXCM stock, worth $1.46 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

18,243

Previous 18,639 2.12%

Holding current value

$1.46 Million

Previous $2.11 Million 42.17%

% of portfolio

0.08%

Previous 0.15%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$64.0 - $116.06 $25,344 - $45,959	-396 Reduced 2.12%	18,243 $1.22 Million
Q2 2024 Aug 01, 2024	SELL	$110.31 - $140.45 $12,906 - $16,432	-117 Reduced 0.62%	18,639 $2.11 Million
Q1 2024 Apr 25, 2024	SELL	$114.22 - $140.1 $75,042 - $92,045	-657 Reduced 3.38%	18,756 $2.6 Million
Q3 2023 Nov 07, 2023	SELL	$86.06 - $137.93 $688 - $1,103	-8 Reduced 0.04%	19,413 $1.81 Million
Q2 2023 Aug 09, 2023	BUY	$112.47 - $130.98 $13,158 - $15,324	117 Added 0.61%	19,421 $2.5 Million
Q1 2023 May 08, 2023	BUY	$104.0 - $122.92 $64,480 - $76,210	620 Added 3.32%	19,304 $2.24 Million
Q4 2022 Feb 21, 2023	SELL	$84.98 - $122.67 $79,201 - $114,328	-932 Reduced 4.75%	18,684 $2.12 Million
Q3 2022 Nov 03, 2022	SELL	$76.35 - $94.18 $243,403 - $300,245	-3,188 Reduced 13.98%	19,616 $1.58 Million
Q2 2022 Jul 15, 2022	BUY	$67.99 - $132.89 $1.1 Million - $2.14 Million	16,109 Added 240.61%	22,804 $1.7 Million
Q1 2022 May 06, 2022	SELL	$94.08 - $130.2 $3,386 - $4,687	-36 Reduced 0.53%	6,695 $3.43 Million
Q4 2021 Jan 31, 2022	SELL	$129.87 - $162.82 $133,376 - $167,216	-1,027 Reduced 13.24%	6,731 $3.61 Million
Q3 2021 Oct 26, 2021	SELL	$106.71 - $143.18 $1,493 - $2,004	-14 Reduced 0.18%	7,758 $4.24 Million
Q2 2021 Aug 03, 2021	SELL	$80.99 - $107.93 $209,764 - $279,538	-2,590 Reduced 25.0%	7,772 $3.32 Million
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $89,707 - $110,814	-1,058 Reduced 9.26%	10,362 $3.72 Million
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $19,890 - $26,647	-255 Reduced 2.18%	11,420 $4.22 Million
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $9,168 - $10,843	-96 Reduced 0.82%	11,675 $4.81 Million
Q2 2020 Aug 18, 2020	SELL	$62.68 - $105.34 $12,097 - $20,330	-193 Reduced 1.61%	11,771 $4.77 Million
Q1 2020 May 21, 2020	BUY	$47.79 - $75.63 $261,124 - $413,242	5,464 Added 84.06%	11,964 $3.22 Million
Q4 2018 Feb 22, 2019	BUY	$26.99 - $37.37 $4,048 - $5,605	150 Added 2.36%	6,500 $779,000
Q3 2018 Nov 15, 2018	BUY	$23.35 - $36.72 $148,272 - $233,172	6,350 New	6,350 $908,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Equitable Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Equitable Trust CO with notifications on news.

Account

Equitable Trust CO Dexcom Inc Transaction History